These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28980209)
1. La Sota vaccination may not protect against virus shedding and the lesions of velogenic Newcastle disease in commercial turkeys. Okoroafor O; Eze PC; Ezema WS; Nwosu C; Okorie-Kanu C; Animoke PC; Anene B; Okoye JOA Trop Anim Health Prod; 2018 Feb; 50(2):345-351. PubMed ID: 28980209 [TBL] [Abstract][Full Text] [Related]
2. Atrophy of the lymphoid organs and suppression of antibody response caused by velogenic Newcastle disease virus infection in chickens. Ezema WS; Eze DC; Shoyinka SV; Okoye JO Trop Anim Health Prod; 2016 Dec; 48(8):1703-1709. PubMed ID: 27645826 [TBL] [Abstract][Full Text] [Related]
3. Triple La Sota re-vaccinations can protect laying chickens for 3 months against drop in egg production caused by velogenic viscerotropic Newcastle disease virus infection. Okechukwu HN; Chukwuedo AA; Eze DC; Igwe AO; Ihedioha JI; Okoye JOA Vet Med Sci; 2020 Aug; 6(3):470-476. PubMed ID: 31995272 [TBL] [Abstract][Full Text] [Related]
4. LaSota vaccination may not protect against the lesions of velogenic Newcastle disease in chickens. Ezema WS; Okoye JO; Nwanta JA Trop Anim Health Prod; 2009 Apr; 41(4):477-84. PubMed ID: 18651236 [TBL] [Abstract][Full Text] [Related]
5. Pathology and Distribution of Velogenic Viscerotropic Newcastle Disease Virus in the Reproductive System of Vaccinated and Unvaccinated Laying Hens (Gallus gallus domesticus) by Immunohistochemical Labelling. Igwe AO; Afonso CL; Ezema WS; Brown CC; Okoye JOA J Comp Pathol; 2018 Feb; 159():36-48. PubMed ID: 29599004 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of viable and inactivated Newcastle disease virus vaccines in turkeys. Kelleher CJ; Halvorson DA; Newman JA Avian Dis; 1988; 32(2):342-6. PubMed ID: 3401177 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of commercial inactivated Newcastle disease virus vaccines against Newcastle disease virus genotype VII in broiler chickens. Sedeik ME; Elbestawy AR; El-Shall NA; Abd El-Hack ME; Saadeldin IM; Swelum AA Poult Sci; 2019 May; 98(5):2000-2007. PubMed ID: 30561723 [TBL] [Abstract][Full Text] [Related]
8. Response of domestic geese to lentogenic and velogenic strains of Newcastle disease virus. Bolte AL; Voss M; Vielitz E; Kaleta EF Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):155-9. PubMed ID: 11370475 [TBL] [Abstract][Full Text] [Related]
9. Immunity Elicited by a Turkey Herpesvirus-Vectored Newcastle Disease Vaccine in Turkey Against Challenge With a Recent Genotype IV Newcastle Disease Virus Field Strain. El Khantour A; Darkaoui S; Tatár-Kis T; Mató T; Essalah-Bennani A; Cazaban C; Palya V Avian Dis; 2017 Sep; 61(3):378-386. PubMed ID: 28957008 [TBL] [Abstract][Full Text] [Related]
10. Viscerotropic velogenic Newcastle disease in Turkeys: virus shedding and persistence of infection in susceptible and vaccinated poults. Gillette KG; Coria MF; Boney WA; Stone HD Avian Dis; 1975; 19(1):31-9. PubMed ID: 1120035 [TBL] [Abstract][Full Text] [Related]
11. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak. Kapczynski DR; King DJ Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366 [TBL] [Abstract][Full Text] [Related]
12. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions. Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and transmissibility of Newcastle disease I-2 vaccine strain against a field isolate of virulent ND virus (JF820294.1) in village chicken. Habibi H; Nili H; Asasi K; Mosleh N; Firouzi S; Mohammadi M Trop Anim Health Prod; 2015 Jan; 47(1):73-8. PubMed ID: 25307759 [TBL] [Abstract][Full Text] [Related]
15. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine. Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117 [TBL] [Abstract][Full Text] [Related]
16. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens. Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237 [TBL] [Abstract][Full Text] [Related]
17. Saponin-adjuvanted vaccine protects chickens against velogenic Newcastle disease virus. El-Dabae WH; Hussein HA; Rohaim MA; El-Safty MM; Ata NS; Reda IM Arch Virol; 2018 Sep; 163(9):2423-2432. PubMed ID: 29968048 [TBL] [Abstract][Full Text] [Related]
18. Day-old vaccination of maternally immune turkeys against Newcastle disease. Box PG; Robertson WW; Warden D Vet Rec; 1978 Jan; 102(1):10-1. PubMed ID: 556306 [TBL] [Abstract][Full Text] [Related]
19. Vaccination of chickens against Newcastle disease with live and inactivated Newcastle disease virus. Winterfield RW; Dhillon AS; Alby LJ Poult Sci; 1980 Feb; 59(2):240-6. PubMed ID: 7413554 [TBL] [Abstract][Full Text] [Related]
20. Viscerotropic velogenic Newcastle disease in turkeys: immune response following vaccination with either viable B1 strain or inactivated vaccine. Boney WA; Stone HD; Gillette KG; Coria MF Avian Dis; 1975; 19(1):19-30. PubMed ID: 1120031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]